NIOSH List of Antineoplastic and Other Hazardous Drugs in ...

  • Pdf File 681.65KByte

´╗┐NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health

NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention

National Institute for Occupational Safety and Health

This document is in the public domain and may be freely copied or reprinted.

Disclaimer

Mention of any company or product does not constitute endorsement by the National Institute for Occupational Safety and Health (NIOSH). In addition, citations of websites external to NIOSH do not constitute NIOSH endorsement of the sponsoring organizations or their programs or products. Furthermore, NIOSH is not responsible for the content of these websites.

Ordering Information

To receive documents or other information about occupational safety and health topics, contact NIOSH at Telephone: 1-800-CDC-INFO (1-800-232-4636) TTY: 1-888-232-6348 CDC-INFO: or visit the NIOSH website at niosh. For a monthly update on news at NIOSH, subscribe to NIOSH eNews by visiting niosh/eNews.

Suggested Citation

NIOSH [2016]. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. By Connor TH, MacKenzie BA, DeBord DG, Trout DB, O'Callaghan JP. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication Number 2016-161 (Supersedes 2014-138).

NIOSH evaluation of hazardous drugs does not cover NIOSH classification of chemical carcinogens. Although NIOSH hazardous drug evaluation includes consideration of carcinogenicity and genotoxicity, this evaluation is tailored to identify and evaluate data from human toxicity profiles, animal studies and in vitro studies unique to evaluating therapeutic agents. For example, NIOSH consults a variety of resources including, but not limited to, safety data sheets, product labeling approved by the U.S. Food and Drug Administration and databases such as DailyMed and DrugBank. For more information on NIOSH classification of chemical carcinogens see "NIOSH Chemical Carcinogen Policy," .

DHHS (NIOSH) Publication No. 2016-161 September 2016

ii

List of Acronyms

AHFS ASHP

BCG BSC CACI CFR CSTD DPI EPA FDA HEPA HIPEC IARC IV MRHD MSHG NIOSH OEL OSHA ONS PPE SC SDS USP

American Hospital Formulary Service American Society of Health-System Pharmacists (formerly, American Society

of Hospital Pharmacy) Bacillus Calmette?Gu?rin Biological safety cabinet Compounding aseptic containment isolator Code of Federal Regulations Closed system drug-transfer device Drug package insert Environmental Protection Agency Food and Drug Administration High-efficiency particulate air Heated intraperitoneal chemotherapy International Agency for Research on Cancer Intravenous Maximum Recommended Human Dose Manufacturer's safe handling guidance National Institute for Occupational Safety and Health Occupational exposure limit Occupational Safety and Health Administration Oncology Nursing Society Personal protective equipment Subcutaneous Safety Data Sheet (formerly Material Safety Data Sheet) United States Pharmacopeial Convention

iii

................
................

Online Preview   Download